Samalin Investment Counsel’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $275K | Sell |
523
-350
| -40% | -$184K | 0.11% | 261 |
|
|
2025
Q1 | $554K | Buy |
873
+117
| +15% | +$74.2K | 0.22% | 138 |
|
|
2024
Q4 | $539K | Sell |
756
-35
| -4% | -$24.9K | 0.23% | 132 |
|
|
2024
Q3 | $832K | Buy |
791
+103
| +15% | +$108K | 0.36% | 77 |
|
|
2024
Q2 | $723K | Buy |
688
+5
| +0.7% | +$5.26K | 0.34% | 83 |
|
|
2024
Q1 | $657K | Sell |
683
-22
| -3% | -$21.2K | 0.31% | 95 |
|
|
2023
Q4 | $619K | Sell |
705
-5
| -0.7% | -$4.39K | 0.31% | 100 |
|
|
2023
Q3 | $584K | Sell |
710
-8
| -1% | -$6.58K | 0.34% | 90 |
|
|
2023
Q2 | $516K | Sell |
718
-40
| -5% | -$28.7K | 0.28% | 107 |
|
|
2023
Q1 | $623K | Sell |
758
-4
| -0.5% | -$3.29K | 0.38% | 74 |
|
|
2022
Q4 | $550K | Sell |
762
-53
| -7% | -$38.2K | 0.35% | 87 |
|
|
2022
Q3 | $561K | Buy |
815
+43
| +6% | +$29.6K | 0.41% | 67 |
|
|
2022
Q2 | $456K | Sell |
772
-187
| -19% | -$110K | 0.32% | 96 |
|
|
2022
Q1 | $670K | Hold |
959
| – | – | 0.41% | 70 |
|
|
2021
Q4 | $606K | Hold |
959
| – | – | 0.36% | 77 |
|
|
2021
Q3 | $580K | Buy |
959
+44
| +5% | +$26.6K | 0.38% | 77 |
|
|
2021
Q2 | $511K | Buy |
+915
| New | +$511K | 0.33% | 99 |
|
|
2020
Q1 | – | Sell |
-100
| Closed | -$37K | – | 438 |
|
|
2019
Q4 | $37K | Buy |
+100
| New | +$37K | 0.03% | 317 |
|